Cera Trials at Home

📊 Data is the new lifeblood of clinical research – but only if it’s the right data. Most clinical trials fail at the recruitment stage because they rely on "snapshot" data from infrequent hospital visits. At Cera, we’ve built Europe’s largest home healthcare dataset, capturing over 300 billion+ health data points. This isn't just a database; it’s a living, breathing map of patient health. The Cera Advantage: 🔎Continuous Monitoring: Our 10,000+ carers log patient symptoms, observations and wellbeing during >2.5 million home visits every month. 🏘️ Beyond the Clinic: We capture "Real-World Evidence" that traditional electronic health records (EHRs) miss, from medication adherence to early signs of respiratory decline. 🎯Precision Matching: We can identify participants for COPD, cardiovascular or dementia studies with pinpoint accuracy before they ever step foot in a screening centre. By moving from reactive searches to proactive data-matching, we’re slashing screen failure rates and getting life-changing treatments to patients faster. #BigData #HealthTech #RealWorldEvidence #ClinicalResearch #TeamCera #CTAH

The UK’s 150-day clinical trial target isn't just a goal – it’s now the baseline 🇬🇧 The Government recently confirmed that commercial trial set-up times have dropped to an average of 122 days. This is a massive win for UK competitiveness, but at Cera, we’re asking: How do we make sure these faster trials reach the people who need them most? While setup times are falling, chronic under-recruitment remains a challenge, particularly for the over-65s, who are frequently sidelined from research meant to help them. How Cera Trials at Home is supporting the UK’s research ambitions:  🏠 Accessibility: We’re bridging the gap between frontline care and medical research by bringing trial opportunities directly to patients' homes. 📊 Data-Driven Recruitment: With a dataset of 300 billion+ patient health data points, we provide the real-world evidence needed to identify eligible participants for conditions like dementia, cancer, and COPD with pinpoint accuracy.  🤝 Strategic Partnerships: Through collaborations with organisations like Re:Cognition Health and GlobalMinds, we are ensuring that mobility or geography no longer determines who gets a seat at the table of global drug discovery. The Government has unlocked the speed. Now, it’s time to unlock the reach. Let’s ensure the UK’s new "predictable pathway" leads straight to the homes of our most vulnerable citizens. #ClinicalTrials #UKLifeSciences #HealthTech #DataDrivenHealth #InclusiveResearch #AgeingPopulation #CTAH

The UK’s 150-day clinical trial target isn't just a goal – it’s now the baseline 🇬🇧 The Government recently confirmed that commercial trial set-up times have dropped to an average of 122 days. This is a massive win for UK competitiveness, but at Cera, we’re asking: How do we make sure these faster trials reach the people who need them most? While setup times are falling, chronic under-recruitment remains a challenge, particularly for the over-65s, who are frequently sidelined from research meant to help them. How Cera Trials at Home is supporting the UK’s research ambitions:  🏠 Accessibility: We’re bridging the gap between frontline care and medical research by bringing trial opportunities directly to patients' homes. 📊 Data-Driven Recruitment: With a dataset of 300 billion+ patient health data points, we provide the real-world evidence needed to identify eligible participants for conditions like dementia, cancer, and COPD with pinpoint accuracy.  🤝 Strategic Partnerships: Through collaborations with organisations like Re:Cognition Health and GlobalMinds, we are ensuring that mobility or geography no longer determines who gets a seat at the table of global drug discovery. The Government has unlocked the speed. Now, it’s time to unlock the reach. Let’s ensure the UK’s new "predictable pathway" leads straight to the homes of our most vulnerable citizens. #ClinicalTrials #UKLifeSciences #HealthTech #DataDrivenHealth #InclusiveResearch #AgeingPopulation #CTAH

We’re excited to announce a new partnership with uMed to move clinical research out of the lab and into the community 🔬 🧬 By connecting our national home care network with uMed’s platform, we’re bridging the gap between frontline care and life-changing science: Cera provides the insight – drawing on our world-leading dataset to rapidly and safely identify the people who would most benefit from access to trials, and match them with the right research 📊 uMed handles registration – taking care of everything from reaching out to patients to helping them sign up. It’s a safe, ethical, and easy way to join a study without the usual stress 📲 Together, we’re making research work for everyone by removing the old barriers: 🏠 Home-first access – no more stressful travel to hospitals. People can participate from the comfort of their own living room.  🤝 Built-in support – tackling digital exclusion as our frontline teams are there to help, so technology is a bridge, not a barrier.  💡 Awareness – reaching the populations who are often overlooked, ensuring research finally focuses on those who need it most. We’re ensuring that more people have the opportunity to participate in research, no matter their age or location 🏘️ 🔗 Read more about the partnership in Health Tech World: https://lnkd.in/ewsBRUrc #ClinicalTrials #DecentralisedTrials #HealthcareResearch #HealthTech #TeamCera #PatientAccess Cera Trials at Home

Clinical trials have a ‘last mile’ problem. While care is increasingly delivered closer to home, much of the UK’s clinical research infrastructure is still centred around hospitals. The result? Recruitment challenges and entire patient groups – particularly older people – are left out of research.🔬 Philip Austin, Director of Research Partnerships at Cera, explores why solving the recruitment crisis means moving beyond hospital walls – and how programmes like Cera Trials at Home can help bring research opportunities directly to patients. Read Philip’s piece in full 👇 #ClinicalTrials #ResearchAccess #DecentralizedTrials #HealthcareInnovation

We’re thrilled to launch Cera Trials at Home – bringing regulated clinical research directly to the homes of older people across the UK. 🔬🏘️ Trials at Home is part of Cera, the UK’s largest domiciliary care provider, where thousands of frontline carers deliver millions of patient home visits every month, with a world-leading home healthcare dataset comprising 300 billion+ health data points on how our population is ageing. Cera Trials at Home offers a unique care-embedded model, enabling Life Sciences companies and CROs to: 🏘️ Reach tens of thousands of over-65s across the UK 👥 Improve diversity and representation in clinical trials 🤝 Support recruitment, retention and real-world evidence generation 🧬 Accelerate the development of treatments for age-related diseases Swipe through to learn how Cera Trials at Home can support your research programme 👇 #HealthcareResearch #ClinicalTrials #CTAH #HealthTech